Gwendolyn H.M.J. Griffioen

Author

Amsterdam UMC Location Vrije Universiteit Amsterdam

Also Known As

G. Griffioen, G.H. Griffioen, G.H.M. Griffioen, G.H.M.J. Griffioen, Gwendolyn Griffioen, Gwendolyn H.M.J. Griffioen

Publications

2.3K

Citations

H-Index

Concepts

All Affiliations

Amsterdam UMC Location Vrije Universiteit Amsterdam Nova Scotia Cancer Centre Beatson West of Scotland Cancer Centre London Health Sciences Centre Alfred Health

About

Gwendolyn H.M.J. Griffioen is an author at Amsterdam UMC Location Vrije Universiteit Amsterdam specializing in medicine, radiation oncology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	2.3K
2	Health Sciences	5	5	2K
3	Radiation Medicine	3	3	195
4	Pathology	1	1	29
5	Surgical Oncology	1	1	107

Gwendolyn H.M.J. Griffioen

Publications

2.3K

Citations

H-Index

Page 1

	Year	Citations
Stereotactic ablative radiotherapy versus standard of care palliative treatment in patients with oligometastatic cancers (SABR-COMET): a randomised, phase 2, open-label trial David A. Palma, Robert Olson, Stephen Harrow, The Lancet Open-label TrialRadiation TherapyMedicineOligometastatic CancersStereotactic Ablative Radiotherapy	2019	1.8K
Radical treatment of synchronous oligometastatic non-small cell lung carcinoma (NSCLC): Patient outcomes and prognostic factors Gwendolyn H.M.J. Griffioen, Daniel Toguri, Max Dahele, Lung Cancer Prognostic FactorsRadical TreatmentMedicinePatient OutcomesBronchial Neoplasm	2013	156
Stereotactic Ablative Radiation Therapy for the Comprehensive Treatment of Oligometastatic Tumors (SABR-COMET): Results of a Randomized Trial David A. Palma, Robert Olson, Stephen Harrow, International Journal of Radiation OncologyBiologyPhysics Neuro-oncologyComprehensive TreatmentSurgical OncologyRadiation MedicineOligometastatic Tumors	2018	107
Quality of Life Outcomes After Stereotactic Ablative Radiation Therapy (SABR) Versus Standard of Care Treatments in the Oligometastatic Setting: A Secondary Analysis of the SABR-COMET Randomized Trial Robert Olson, Suresh Senan, Stephen Harrow, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineLife OutcomesRadiation TherapyMedicineBrachytherapy	2019	58
Treatment of multiple primary lung cancers using stereotactic radiotherapy, either with or without surgery Gwendolyn H.M.J. Griffioen, Frank J. Lagerwaard, Cornelis J.A. Haasbeek, Radiotherapy and Oncology Adaptive RadiotherapyRadiation TherapyMedicineRadionuclide TherapyBronchial Neoplasm	2013	56
High-dose, conventionally fractionated thoracic reirradiation for lung tumors Gwendolyn H.M.J. Griffioen, Max Dahele, Patricia F. de Haan, Lung Cancer Lung TumorsRadiation TherapyMedicineLung CancerOncology	2013	47
Comparing rigid and deformable dose registration for high dose thoracic re-irradiation Sashendra Senthi, Gwendolyn H.M.J. Griffioen, John R. van Sörnsen de Koste, Radiotherapy and Oncology Adaptive RadiotherapyRadiation MedicineRadiation TherapyMedical ImagingDeformable Dose Registration	2013	30
Second primary lung cancers following a diagnosis of primary head and neck cancer Gwendolyn H.M.J. Griffioen, Alexander V. Louie, Remco de Bree, Lung Cancer Primary HeadNeck CancerMedicineMultiple Pulmonary NoduleNasopharyngeal Cancer	2015	29
A Brief Report on Outcomes of Stereotactic Ablative Radiotherapy for a Second Primary Lung Cancer: Evidence in Support of Routine CT Surveillance Gwendolyn H.M.J. Griffioen, Frank J. Lagerwaard, Cornelis J.A. Haasbeek, Journal of Thoracic Oncology Adaptive RadiotherapyHealth SciencesRadiation TherapyMedicineBrief Report	2014	16

Page 1